menu
    • menu

    Company profile for Asgard Therapeutics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are exploring direct cell reprogramming as a strategy to force cancer cells to become immunogenic again. It is specialized in R&D and in the use of direct cell reprogramming technologies for cancer immunotherapy. We aim to use our direct reprogramming discoveries to contribute to create a positive impact in patients life.We are committed to the challenge of making cancer immunotherapies available for every patient.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Asgard TherapeuticsSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Lund, Sköna 221 84
    Telephone
    Telephone
    +46 (0) 73 156 60 72
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.asgardthx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/asgardthx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AsgardThx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Asgard Therapeutics To Unveil AT-108, Gene Therapy Data At AACR
    Asgard Therapeutics To Unveil AT-108, Gene Therapy Data At AACR

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187984

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    Asgard Therapeutics To Unveil AT-108, Gene Therapy Data At AACR
    Asgard Therapeutics To Unveil AT-108, Gene Therapy Data At AACR

    17 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/17/3276450/0/en/Asgard-Therapeutics-to-present-preclinical-data-on-lead-asset-AT-108-a-personalized-off-the-shelf-gene-therapy-at-AACR-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    17 Apr 2026
    Share Share
    Asgard Therapeutics Appoints Brugger as Chief Medical Officer
    Asgard Therapeutics Appoints Brugger as Chief Medical Officer

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273034/0/en/Asgard-Therapeutics-appoints-Professor-Dr-Wolfram-Brugger-as-Chief-Medical-Officer-as-it-advances-transformative-personalized-off-the-shelf-immunotherapy-toward-clinical-developmen.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Asgard Therapeutics boosts Board with Drug Dev, Cancer Experts
    Asgard Therapeutics boosts Board with Drug Dev, Cancer Experts

    03 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/asgard-therapeutics-strengthens-its-board-of-directors-and-advisory-board-with-leading-experts-in-drug-development-and-cancer-immunotherapy-302471673.html

    PR NEWSWIRE
    03 Jun 2025
    Share Share
    Asgard Therapeutics names Shane Olwill Chief Development Officer
    Asgard Therapeutics names Shane Olwill Chief Development Officer

    26 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/asgard-therapeutics-appoints-immunology-expert-shane-olwill-as-chief-development-officer-302411072.html

    PR NEWSWIRE
    26 Mar 2025
    Share Share
    Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy
    Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy

    11 Jun 2024

    // PRESS RELEASE

    https://exothera.world/asgard-therapeutics-selects-exothera-to-bring-their-viral-vector-based-immunotherapy-candidate-at-108-to-clinical-trial-stage/

    PRESS RELEASE
    11 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search